However, the significant association between TGFB1+915 CG/CC genotypes and 2-year survival for all gastric cancer patients suggests that this TGFB1variant may have attenuated the role of TGF-β1 as a tumor suppressor in the earlier stage of tumor progression. Here, TGFB1 is linked to gastric cancer.